» Articles » PMID: 16283099

Neuropsychological Function in Relation to Serum Parathyroid Hormone and Serum 25-hydroxyvitamin D Levels. The Tromsø Study

Overview
Journal J Neurol
Specialty Neurology
Date 2005 Nov 12
PMID 16283099
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

There are receptors for parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D in the brain, and there are clinical and experimental data indicating that PTH and vitamin D may affect cerebral function. In the present study 21 subjects who both in the 5th Tromsø study and at a follow-up examination fulfilled criteria for secondary hyperparathyroidism (SHPT) without renal failure (serum calcium < 2.40 mmol/L, serum PTH > 6.4 pmol/L, and normal serum creatinine) and 63 control subjects were compared with tests for cognitive and emotional function. Those in the SHPT group had significantly impaired performance in 3 of 14 cognitive tests (Digit span forward, Stroop test part 1 and 2, and Word association test (FAS)) as compared with the controls, and also had a significantly higher depression score at the Beck Depression Inventory (BDI) (items 1-13). In a multiple linear regression model, a high serum PTH level was significantly associated with low performance at the Digit span forward, Stroop test part 1 and 2, and Digit Symbol tests. A low level of serum 25-hydroxyvitamin D was significantly associated with a high depression score. In conclusion, a deranged calcium metabolism appears to be associated with impaired function in several tests of neuropsychological function.

Citing Articles

Secondary Hyperparathyroidism and Cognitive Decline.

Crepeau P, Fedorova T, Morris-Wiseman L, Mathur A Curr Transplant Rep. 2024; 10(2):60-68.

PMID: 38707996 PMC: 11068066. DOI: 10.1007/s40472-023-00394-5.


Cognitive Function and Vitamin D Status in the Chinese Hemodialysis Patients.

Zhang J, Hu J, Zhou R, Xu Y Comput Math Methods Med. 2022; 2022:2175020.

PMID: 36118837 PMC: 9481383. DOI: 10.1155/2022/2175020.


Case report: Reoperative parathyroidectomy for large ectopic hyperplastic parathyroid in the mediastinum of a patient with recurrent secondary hyperparathyroidism.

Lv Y, Wang Q, Zhang L, Zhou Q, Mi Z, Wu Y Front Surg. 2022; 9:921026.

PMID: 35965874 PMC: 9363666. DOI: 10.3389/fsurg.2022.921026.


High-dose Vitamin D Supplementation and Improvement in Cognitive Abilities, Insomnia, and Daytime Sleepiness in Adolescent Girls.

Bahrami A, Rezaeitalab F, Farahmand S, Mazloum Khorasani Z, Arabi S, Bahrami-Taghanaki H Basic Clin Neurosci. 2021; 12(3):339-348.

PMID: 34917293 PMC: 8666927. DOI: 10.32598/bcn.2021.1910.1.


Short- and Long-Term Effects of Vitamin D Treatment on Bacillus Calmette-Guerin-Induced Depressive-Like Behavior in Mice.

Saleh L, Almutairi F, Alorabi W, Alkuhayli B, Alzaidi S, Alzahrani S Neuropsychiatr Dis Treat. 2021; 17:711-720.

PMID: 33688194 PMC: 7936677. DOI: 10.2147/NDT.S291793.


References
1.
Juppner H, Abou-Samra A, Freeman M, Kong X, Schipani E, Richards J . A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science. 1991; 254(5034):1024-6. DOI: 10.1126/science.1658941. View

2.
Bonaa K, Arnesen E . Association between heart rate and atherogenic blood lipid fractions in a population. The Tromsø Study. Circulation. 1992; 86(2):394-405. DOI: 10.1161/01.cir.86.2.394. View

3.
Jorde R, Bonaa K, Sundsfjord J . Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Tromsø study. Eur J Endocrinol. 1999; 141(4):350-7. DOI: 10.1530/eje.0.1410350. View

4.
Hirasawa T, Nakamura T, Mizushima A, Morita M, Ezawa I, Miyakawa H . Adverse effects of an active fragment of parathyroid hormone on rat hippocampal organotypic cultures. Br J Pharmacol. 2000; 129(1):21-8. PMC: 1621111. DOI: 10.1038/sj.bjp.0702949. View

5.
Huppert F, Walters D, Day N, Elliott B . The factor structure of the General Health Questionnaire (GHQ-30). A reliability study on 6317 community residents. Br J Psychiatry. 1989; 155:178-85. DOI: 10.1192/bjp.155.2.178. View